Celgene and Forma extend discovery pact | September 4, 2017 Issue - Vol. 95 Issue 35 | Chemical & Engineering News
Volume 95 Issue 35 | p. 17 | Concentrates
Issue Date: September 4, 2017

Celgene and Forma extend discovery pact

Department: Business
Keywords: Drug discovery, inflammation, small molecules, Celgene

Celgene will put another $195 million into Forma Therapeutics to expand their small-molecule drug discovery partnership to include targets in the areas of protein homeostasis, inflammation,immunology, and neurodegeneration. Forma is based in Watertown, Mass., with chemistry operations in Branford, Conn. The two firms established their pact in 2013 and extended it in 2014.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment